Lexaria Bioscience (LEXX) Net Income Growth (1y) (2018 - 2026)
Lexaria Bioscience (LEXX) Net Income Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
-43.69% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-290.15% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
-73.01% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Lexaria Bioscience |
7.49 Mn |
1.97 Mn |
20,000.00 |
47.19% |
| Date | Value |
|---|
| Feb 28, 2026 |
47.19% |
| Nov 30, 2025 |
41.45% |
| Aug 31, 2025 |
-22.30% |
| May 31, 2025 |
-115.17% |
| Feb 28, 2025 |
-311.82% |
| Nov 30, 2024 |
-137.73% |
| Aug 31, 2024 |
-97.11% |
| May 31, 2024 |
27.40% |
| Feb 29, 2024 |
49.53% |
| Nov 30, 2023 |
33.24% |
| Aug 31, 2023 |
-48.84% |
| May 31, 2023 |
0.72% |
| Feb 28, 2023 |
8.63% |
| Nov 30, 2022 |
15.38% |
| Feb 28, 2022 |
-5,694.69% |
| Nov 30, 2021 |
-66,882.73% |
| Feb 28, 2021 |
-138.95% |
| Nov 30, 2020 |
-94.16% |
| Aug 31, 2020 |
98.24% |
| May 31, 2020 |
101.65% |
